January 11, 2022
FDA: Class I recall of Cardiovascular Systems’ WIRION Embolic Protection Device
Editor's Note
The Food and Drug Administration (FDA), on January 10, identified the recall of Cardiovascular Systems’ WIRION Embolic Protection Device as Class I, the most serious.
The device, which is used to hold or remove debris or blood clots from the lower limbs, was recalled because of complaints of filter breakage during retrieval.
Cardiovascular Systems has received reports of nine device malfunctions and no reports of deaths.
Distribution dates were March 22, 2021, to November 15, 2021.
Free Daily News
- Enhanced PPE among updates to improve instrument sterilization safety
- First transatlantic robotic thrombectomy performed
- Joint Commission releases National Performance Goal briefs
- Review on pneumatic tourniquet safety
- Coronary computed tomography angiography helps predict first coronary events
- Environment influences OR team performance
- Ambulatory shift transforming care models for high-acuity patients
- How to improve outpatient first case starts
- Engage anesthesia group to expand volume
- Ethical considerations for deploying AI in surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement